Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) & Region - Global Forecast to 2027
Market Growth Outlook Summary
The global interventional cardiology devices market growth forecasted to transform from $17.5 billion in 2022 to $25.5 billion by 2027, driven by a CAGR of 7.7%. This market is driven by the increasing prevalence of cardiovascular diseases, largely attributed to rising tobacco consumption and obesity. The demand for devices such as angioplasty balloons, stents, catheters, and embolic protection devices is expected to grow. Key players like Medtronic, Boston Scientific, and Abbott dominate the market, with Boston Scientific leading in innovations. North America holds the largest market share, followed by Japan in the APAC region. Product approvals, such as Biotronik’s Orsiro Mission Drug-eluting Stent, are expected to fuel further growth.
Interventional Cardiology Devices Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Interventional Cardiology Devices Market Dynamics
Driver: Rising tobacco consumption and increasing incidence of obesity
Smoking and obesity are directly linked to cardiovascular diseases. Smoking increases the formation of plaque in the blood vessels. Chemicals in cigarette smoke also cause the blood to thicken and form clots inside veins and arteries. Coronary heart disease occurs when the arteries that carry blood to the heart are narrowed by plaque or blocked by clots. Owing to this, smokers are at a much higher risk of developing CAD than non-smokers. According to the CDC, more than 480,000 people die from cigarette smoking in the US alone every year. Globally, more than 7 million people die each year due to cigarette smoking. By 2030, more than 8 million people are expected to die annually from diseases caused due to tobacco consumption.
Obesity, like cigarette smoking, also leads to heart disease. Obese individuals generally require more blood to supply oxygen and nutrients to their bodies, increasing blood pressure. High blood pressure is a common cause of heart disease. Thus, cigarette smoking and obesity are expected to increase the demand for cardiovascular devices, including interventional cardiology devices, in the coming years.
According to an article published in the Lancet Journal in October 2016, the global prevalence of interventional cardiology diseases was 115.1 million in 2005, which rose to 154.6 million in 2015. With the growing geriatric population in all major regions across the globe, the prevalence of interventional cardiology diseases is expected to increase further in the coming years. This, in turn, will increase the demand and uptake of interventional cardiology devices in major markets during the forecast period.
Opportunity: Increasing number of product approvals
In recent years, an increasing number of key players operating in the market have strengthened their product offerings by launching new and advanced products. Some recent product approvals in the market include:
- In 2020, Biotronik SE & Co. KG received CE mark approval for Orsiro Mission Drug-eluting Stent.
- In 2020, Meril Life Sciences received CE mark approval for MeRes 100 Bioresorbable Scaffold
These product launches by key players such as Medtronic, Abbott, and BIOTRONIK SE & Co. KG in major markets are expected to increase end-user access to advanced products with innovative features to treat coronary artery diseases. This, in turn, is expected to fuel market growth.
Embolic protection devices accounted for the largest share of the interventional cardiology devices industry
Based on type, the interventional cardiology devices market has been categorized into embolic protection devices and chronic total occlusion devices. Among both, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of embolic protection devices over chronic total occlusion devices, such as the ability to capture embolic debris without interrupting continuous blood flow. Moreover, an increasing number of interventional procedures for treating coronary artery diseases.
Japan is anticipated to account the largest share of APAC interventional cardiology devices industry
Based on the APAC region, the interventional cardiology devices market is divided into China, Japan, India, Australia, and Rest of APAC. Japan is expected to account the largest share of the market. The rising geriatric population and the subsequent growth in the country's prevalence of target diseases are the major factors supporting the growth of the Interventional cardiology devices in China.
North America dominates the global interventional cardiology devices industry
Based on the region, the interventional cardiology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of World. North America is expected to dominate the market. Growth in the North American market is mainly driven by the rising prevalence of cardiology diseases, high healthcare expenditure, and high disposable incomes.
Prominent players in the interventional cardiology devices market are Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).
Boston Scientific is the leading player in the market. The company offers a wide range of guidewires, stents, catheters, angioplasty balloons, and structural heart devices. In the last three years, the company has been focusing on expanding its interventional cardiology portfolio by adopting various organic and inorganic strategies. Apart from this, the company has a strong presence in the US. As a result, in 2019, the company registered ~46% of its total interventional cardiology revenue from the US alone.
Interventional Cardiology Devices Market Report Scope
|
Report Metric |
Details |
|
Market Revenue Size in 2022 |
$17.5 billion |
|
Projected Revenue Size by 2027 |
$25.5 billion |
|
Industry growth Rate |
Poised to grow at a CAGR of 7.7% |
|
Market Driver |
Rising tobacco consumption and increasing incidence of obesity |
|
Market Opportunity |
Increasing number of product approvals |
This study categorizes the global interventional cardiology devices market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Angioplasty Balloons
- Old/Normal Balloons
- Drug-eluting Balloons
- Cutting and Scoring Balloons
-
Angioplasty Stents
- Drug-eluting Stents
- Bare-metal Stents
- Bioabsorbable Stents
-
Structural Heart Devics
- Aortic Valve Therapy Devices
- Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
-
Catheters
- Angiography Catheters
- Guiding Catheters
- IVUS/OCT Catheters
-
Plaque Modification Devices
- Atherectomy Devices
- Thrombectomy Devices
-
Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
-
Other Devices
- Guidewires
- Vascular Closure Devices
- Introducer Sheaths
- Hemostasis Valves
- Balloon Inflation Devices
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- Middle East and Africa
Recent Developments of Interventional Cardiology Devices Industry:
- In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery
- In 2020, Biotronk SE & Co. KG, Received CE approval for its Orsiro Mission Drug-eluting Stent.
- In 2020, SMT (India) acquired Vascular Concept (India) to expand its structural heart product portfolio
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global interventional cardiology devices market?
The global interventional cardiology devices market boasts a total revenue value of $25.5 billion by 2027.
What is the estimated growth rate (CAGR) of the global interventional cardiology devices market?
The global interventional cardiology devices market has an estimated compound annual growth rate (CAGR) of 7.7% and a revenue size in the region of $17.5 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Bottom-up approach for the interventional cardiology devices market
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 37)
FIGURE 7 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 OTHER MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 42)
4.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET OVERVIEW
FIGURE 15 INCREASING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE GROWTH IN THE MARKET
4.2 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 16 DRUG-ELUTING STENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
4.3 NORTH AMERICAN MARKET, BY CATHETER TYPE AND COUNTRY
FIGURE 17 THE US IS EXPECTED TO DOMINATE THE MARKET IN 2020
4.4 GLOBAL MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of coronary artery disease
FIGURE 20 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2030 VS. 2045
5.2.1.2 Rising tobacco consumption and increasing incidence of obesity
5.2.1.3 Favorable reimbursements for interventional cardiology procedures
TABLE 1 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES IN THE US
5.2.2 RESTRAINTS
5.2.2.1 Availability of alternative treatments
5.2.2.2 Low affordability and inaccessibility of cardiac surgeries in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential of emerging economies
5.2.3.2 Increasing number of product approvals
TABLE 2 RECENT APPROVALS OF VARIOUS TYPES OF INTERVENTIONAL CARDIOLOGY DEVICES, 2018–2020
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements delaying the approval of cardiac devices
5.2.4.2 Product failures and recalls
5.3 COVID-19 IMPACT ON THE MARKET
5.4 PRICING ANALYSIS
TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES, AVERAGE SELLING PRICES (USD)
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.7 ECOSYSTEM ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.9 REGULATORY LANDSCAPE
5.1 PESTLE ANALYSIS
6 ANGIOPLASTY STENTS MARKET, BY TYPE (Page No. - 58)
6.1 INTRODUCTION
TABLE 4 ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.1.1 DRUG-ELUTING STENTS
6.1.1.1 Drug-eluting stents hold the largest share of the angioplasty stents market
TABLE 5 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.2 BARE-METAL STENTS
6.1.2.1 Increasing use of drug-eluting stents has limited the growth of the bare-metal stents market
TABLE 7 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
6.1.3 BIOABSORBABLE STENTS
6.1.3.1 Bioabsorbable stents ensure the complete healing of the arteries—a key factor driving market growth
TABLE 9 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7 STRUCTURAL HEART DEVICES MARKET, BY TYPE (Page No. - 63)
7.1 INTRODUCTION
TABLE 11 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.1.1 AORTIC VALVE THERAPY DEVICES
7.1.1.1 Increasing prevalence of aortic valve stenosis to support the market growth
TABLE 12 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
7.1.2 OTHER THERAPY DEVICES
TABLE 14 OTHER THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
8 CATHETERS MARKET, BY TYPE (Page No. - 66)
8.1 INTRODUCTION
TABLE 15 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
8.1.1 ANGIOGRAPHY CATHETERS
8.1.1.1 Angiography catheters hold the largest share of the catheters market during the forecast period
TABLE 16 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.2 GUIDING CATHETERS
8.1.2.1 Guiding catheters to account for the second-largest share of the catheters market during the forecast period
TABLE 17 GUIDING CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.1.3 IVUS/OCT CATHETERS
8.1.3.1 IVUS/OCT catheters to register the highest growth rate during the forecast period
TABLE 18 IVUS/OCT CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
9 ANGIOPLASTY BALLOONS MARKET, BY TYPE (Page No. - 70)
9.1 INTRODUCTION
TABLE 19 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.1.1 OLD/NORMAL BALLOONS
9.1.1.1 Low treatment costs associated with this technique to drive the growth of the old/normal balloons market
TABLE 20 OLD/NORMAL BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.2 DRUG-ELUTING BALLOONS
9.1.2.1 Rising number of regulatory approvals for drug-eluting balloons to drive market growth during the forecast period
TABLE 21 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
9.1.3 CUTTING/SCORING BALLOONS
9.1.3.1 Use of cutting balloon-aided procedures is very limited since medication is the primary treatment for atherosclerosis
TABLE 22 CUTTING/SCORING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
10 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE (Page No. - 74)
10.1 INTRODUCTION
TABLE 23 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.1.1 THROMBECTOMY DEVICES
10.1.1.1 Thrombectomy devices segment dominates the plaque modification devices market
TABLE 24 THROMBECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
10.1.2 ATHERECTOMY DEVICES
10.1.2.1 Growing use of lipid-modifying drugs for the treatment of atherosclerosis instead of atherectomy devices to limit market growth
TABLE 25 ATHERECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE (Page No. - 77)
11.1 INTRODUCTION
TABLE 26 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
11.1.1 EMBOLIC PROTECTION DEVICES
11.1.1.1 Embolic protection devices to dominate the hemodynamic flow alteration devices market during the forecast period
TABLE 27 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
11.1.2 CHRONIC TOTAL OCCLUSION DEVICES
11.1.2.1 CTO devices market has witnessed tremendous innovations, thereby expanding the options available for physicians
TABLE 28 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE (Page No. - 80)
12.1 INTRODUCTION
TABLE 29 OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.1.1 GUIDEWIRES
TABLE 30 GUIDEWIRES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.2 VASCULAR CLOSURE DEVICES
TABLE 31 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.3 INTRODUCER SHEATHS
TABLE 32 INTRODUCER SHEATHS MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.4 BALLOON INFLATION DEVICES
TABLE 33 BALLOON INFLATION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.1.5 HEMOSTASIS HEART VALVES
TABLE 34 HEMOSTASIS HEART VALVES MARKET, BY REGION, 2018–2025 (USD MILLION)
13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION (Page No. - 84)
13.1 INTRODUCTION
TABLE 35 MARKET, BY REGION, 2018–2025 (USD MILLION)
13.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 36 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.1 US
13.2.1.1 Availability of reimbursements for interventional cardiology procedures to support the market growth
TABLE 44 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 45 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 US: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 US: OTHER INTERVENTIONAL CARDIOLOGY-DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.2.2 CANADA
13.2.2.1 Rising incidence of target diseases to support the market growth
TABLE 52 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 CANADA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 CANADA: OTHER INTERVENTIONAL CARDIOLOGY-DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3 EUROPE
TABLE 59 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.1 GERMANY
13.3.1.1 Germany holds the largest share of the European interventional cardiology devices market
TABLE 67 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 GERMANY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 GERMANY: MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.2 FRANCE
13.3.2.1 Favorable government initiatives in France to support the growth of the market in the country
TABLE 74 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 FRANCE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 FRANCE: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.3 UK
13.3.3.1 High burden of target diseases to drive the market in the country
TABLE 81 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 UK: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.4 SPAIN
13.3.4.1 Growing geriatric population to increase the demand for interventional cardiology devices in the country
TABLE 88 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 SPAIN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 SPAIN: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising levels of obesity to increase the demand for interventional cardiology devices in the country
TABLE 95 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ITALY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.3.6 REST OF EUROPE
TABLE 102 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
TABLE 103 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 ROE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 ROE: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 ASIA PACIFIC: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.1 JAPAN
13.4.1.1 Japan dominates the Asia Pacific market
TABLE 118 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 JAPAN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 JAPAN: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Highest tobacco consumption in the world—a major factor driving market growth in China
TABLE 125 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 CHINA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.3 INDIA
13.4.3.1 Increasing target patient population to drive the market in the country
TABLE 132 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 INDIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 INDIA: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.4 AUSTRALIA
13.4.4.1 Increasing prevalence of heart diseases to support the market growth
TABLE 139 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.4.5 REST OF ASIA PACIFIC
TABLE 146 ROAPAC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROAPAC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROAPAC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 ROAPAC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 ROAPAC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 ROAPAC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 ROAPAC: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5 REST OF THE WORLD
TABLE 153 ROW: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 ROW: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 ROW: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 ROW: OTHER MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.1 LATIN AMERICA
13.5.1.1 Latin America dominates the RoW market
TABLE 161 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
13.5.2 MIDDLE EAST & AFRICA
13.5.2.1 Increasing prevalence of diabetes to support market growth in the Middle East & Africa
TABLE 168 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY-DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
14 COMPETITIVE LANDSCAPE (Page No. - 138)
14.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, JANUARY 2017–NOVEMBER 2020
FIGURE 26 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO NOVEMBER 2020
14.2 COMPETITIVE SCENARIO
14.2.1 AGREEMENTS & PARTNERSHIPS
TABLE 175 KEY AGREEMENTS & PARTNERSHIPS
14.2.2 PRODUCT LAUNCHES & APPROVALS
TABLE 176 KEY PRODUCT LAUNCHES & APPROVALS
14.2.3 EXPANSIONS
TABLE 177 KEY EXPANSIONS
14.2.4 ACQUISITIONS
TABLE 178 KEY ACQUISITIONS
14.2.5 OTHER DEVELOPMENTS
TABLE 179 OTHER DEVELOPMENTS
14.3 MARKET SHARE ANALYSIS, 2019
FIGURE 27 MARKET SHARE ANALYSIS, 2019
14.4 COMPANY EVALUATION MATRIX
14.4.1 STARS
14.4.2 EMERGING LEADERS
14.4.3 PERVASIVE PLAYERS
14.4.4 PARTICIPANTS
FIGURE 28 VENDOR DIVE: GLOBAL MARKET
14.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS/SMES)
14.5.1 PROGRESSIVE COMPANIES
14.5.2 STARTING BLOCKS
14.5.3 RESPONSIVE COMPANIES
14.5.4 DYNAMIC COMPANIES
FIGURE 29 VENDOR DIVE MATRIX FOR START-UPS: MARKET
15 COMPANY PROFILES (Page No. - 147)
(Business overview, Products offered, Recent developments, MNM view)*
15.1 BOSTON SCIENTIFIC CORPORATION
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
15.2 MEDTRONIC PLC
FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
15.3 ABBOTT LABORATORIES
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
15.4 EDWARDS LIFESCIENCES CORPORATION
FIGURE 33 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019)
15.5 TERUMO CORPORATION
FIGURE 34 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
15.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
FIGURE 35 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2019)
15.7 B. BRAUN MELSUNGEN AG
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
15.8 KONINKLIJKE PHILIPS N.V.
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
15.9 IVASCULAR S.L.U.
15.10 BIOSENSORS INTERNATIONAL
15.11 BIOTRONIK SE & CO. KG
15.12 PENUMBRA, INC.
FIGURE 38 PENUMBRA, INC: COMPANY SNAPSHOT (2019)
15.13 AMG INTERNATIONAL (A SUBSIDIARY OF Q3 MEDICAL)
15.14 ENDOCOR GMBH
15.15 INSITU TECHNOLOGIES, INC.
15.16 MERIL LIFE SCIENCES PVT. LTD.
15.17 ALVIMEDICA
15.18 CARDIONOVUM GMBH
15.19 SMT
15.20 MEDINOL LTD.
15.21 WELLINQ
15.22 SCITECH
15.23 COMED B.V. (A SUBSIDIARY OF LEPU MEDICAL TECHNOLOGY HOLDING)
15.24 BALTON SP. Z O.O
15.25 RONTIS
15.26 STENTYS SA
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
16 APPENDIX (Page No. - 189)
16.1 INSIGHTS FROM INDUSTRY EXPERTS
16.2 DISCUSSION GUIDE
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 AVAILABLE CUSTOMIZATIONS
16.5 RELATED REPORTS
16.6 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the interventional cardiology devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Several stakeholders, such as interventional cardiology device manufacturers, vendors, and distributors; researchers; and doctors from hospitals and ambulatory surgery centers, were consulted for this report. The demand side of this market is characterized by significant use of interventional cardiology devices due to the increasing prevalence of atherectomy, thrombectomy, and the growing aging population across the globe. The supply side is characterized by advancements in technology and a shift towards advanced devices. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Breakdown Of Primary Participants:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the interventional cardiology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size-using the market size estimation processes-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the interventional cardiology devices industry.
Report Objectives
- To define, describe, and forecast the interventional cardiology devices market by product and region
- To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To identify the micromarkets with respect to drivers, industry-specific challenges, opportunities, and challenges affecting the growth of the market
- To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product launches, and research and development activities in the interventional cardiology devices market.
Generating Response ...
Growth opportunities and latent adjacency in Interventional Cardiology Devices Market
what are the growth opportunities in interventional cardiovascular devices market
Looking forward to gain more insights on the global Interventional Cardiology Devices Market
Can you enlighten us on geographical growth analysis in Interventional Cardiology Devices Market?